Immunitybio Inc (NASDAQ:IBRX)
| 5.70 Delayed Data As of 4:00pm ET |  -0.195 / -3.31%Today’s Change | 2.60 Today|||52-Week Range 7.99 | -6.33% Year-to-Date |
Latest IBRX News | Press Releases
No recent news for Immunitybio Inc.
Today’s Trading
| Previous close | 5.89 |
| Today’s open | 5.88 |
| Day’s range | 5.61 - 5.92 |
| Volume | 31,506 |
| Average volume (3 months) | 1,580,326 |
| Market cap | $2.5B |
Data as of 4:00pm ET, 12/06/2022
Growth & Valuation
| Earnings growth (last year) | +0.13% |
| Earnings growth (this year) | -12.36% |
| Earnings growth (next 5 years) | -47.93% |
| Revenue growth (last year) | +741.44% |
| P/E ratio | NM |
| Price/Sales | 2,533.77 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RCUSArcus Biosciences In... | -2.13 | -6.27% |
| ---- | ||
| BCRXBioCryst Pharmaceuti... | -0.69 | -5.92% |
| MYOVMyovant Sciences Ltd | +0.08 | +0.28% |
Data as of 4:00pm ET, 12/06/2022
Financials
| Last reporting date | November 11, 2022 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $934.0K |
| Annual profit (last year) | -$346.8M |
| Net profit margin | -37,129.55% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
